JP2021534144A5 - - Google Patents
Info
- Publication number
- JP2021534144A5 JP2021534144A5 JP2021507529A JP2021507529A JP2021534144A5 JP 2021534144 A5 JP2021534144 A5 JP 2021534144A5 JP 2021507529 A JP2021507529 A JP 2021507529A JP 2021507529 A JP2021507529 A JP 2021507529A JP 2021534144 A5 JP2021534144 A5 JP 2021534144A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- age
- modified
- antibody
- antibodies
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024098654A JP2024123124A (ja) | 2018-08-23 | 2024-06-19 | Ａｇｅ修飾細胞を除去するための、抗カルボキシメチルリシン抗体及び超音波 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862721932P | 2018-08-23 | 2018-08-23 | |
| US62/721,932 | 2018-08-23 | ||
| PCT/US2019/047762 WO2020041625A1 (en) | 2018-08-23 | 2019-08-22 | Anti carboxymethyl lysine antibodies and ultrasound for removing age-modified cells |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024098654A Division JP2024123124A (ja) | 2018-08-23 | 2024-06-19 | Ａｇｅ修飾細胞を除去するための、抗カルボキシメチルリシン抗体及び超音波 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021534144A JP2021534144A (ja) | 2021-12-09 |
| JP2021534144A5 true JP2021534144A5 (https=) | 2023-05-26 |
Family
ID=68063013
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021507529A Pending JP2021534144A (ja) | 2018-08-23 | 2019-08-22 | Ａｇｅ修飾細胞を除去するための、抗カルボキシメチルリシン抗体及び超音波 |
| JP2024098654A Pending JP2024123124A (ja) | 2018-08-23 | 2024-06-19 | Ａｇｅ修飾細胞を除去するための、抗カルボキシメチルリシン抗体及び超音波 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024098654A Pending JP2024123124A (ja) | 2018-08-23 | 2024-06-19 | Ａｇｅ修飾細胞を除去するための、抗カルボキシメチルリシン抗体及び超音波 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20210253739A1 (https=) |
| EP (1) | EP3840840A1 (https=) |
| JP (2) | JP2021534144A (https=) |
| WO (1) | WO2020041625A1 (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2553225C2 (ru) | 2008-05-23 | 2015-06-10 | Сива Корпорейшн | Способ облегчения регенерации |
| US8721571B2 (en) | 2010-11-22 | 2014-05-13 | Siwa Corporation | Selective removal of cells having accumulated agents |
| EP3194439B1 (en) | 2014-09-19 | 2022-01-19 | Siwa Corporation | Anti-age antibodies for treating inflammation and auto-immune disorders |
| US9993535B2 (en) | 2014-12-18 | 2018-06-12 | Siwa Corporation | Method and composition for treating sarcopenia |
| US10358502B2 (en) | 2014-12-18 | 2019-07-23 | Siwa Corporation | Product and method for treating sarcopenia |
| HUE058854T2 (hu) | 2016-02-19 | 2022-09-28 | Siwa Corp | Módszer és készítmény a rák kezelésére, az áttétes rákos sejtek elpusztítására és a rák áttétképzõdésének megelõzésére a fejlett glikációs végtermékek (AGE) elleni antitest alkalmazásával |
| KR20180133452A (ko) | 2016-04-15 | 2018-12-14 | 시와 코퍼레이션 | 신경퇴행성 질환을 치료하기 위한 항-노화 항체 |
| JP2019518763A (ja) | 2016-06-23 | 2019-07-04 | シワ コーポレーション | 様々な疾患及び障害の治療において使用するためのワクチン |
| US10925937B1 (en) | 2017-01-06 | 2021-02-23 | Siwa Corporation | Vaccines for use in treating juvenile disorders associated with inflammation |
| US10961321B1 (en) | 2017-01-06 | 2021-03-30 | Siwa Corporation | Methods and compositions for treating pain associated with inflammation |
| US10858449B1 (en) | 2017-01-06 | 2020-12-08 | Siwa Corporation | Methods and compositions for treating osteoarthritis |
| US10995151B1 (en) | 2017-01-06 | 2021-05-04 | Siwa Corporation | Methods and compositions for treating disease-related cachexia |
| CA3059803A1 (en) | 2017-04-13 | 2018-10-18 | Siwa Corporation | Humanized monoclonal advanced glycation end-product antibody |
| US11518801B1 (en) | 2017-12-22 | 2022-12-06 | Siwa Corporation | Methods and compositions for treating diabetes and diabetic complications |
| WO2021222084A1 (en) | 2020-04-28 | 2021-11-04 | Siemens Healthcare Diagnostics Inc. | Acoustophoretic lysis devices and methods |
| US20230181730A1 (en) * | 2020-05-01 | 2023-06-15 | Siwa Corporation | Methods of treating infections |
| WO2021247397A2 (en) * | 2020-06-04 | 2021-12-09 | Siwa Corporation | Methods and compositions for enhancing the immune system |
| WO2022093195A1 (en) * | 2020-10-27 | 2022-05-05 | Siwa Corporation | Methods and compositions for treating osteoarthritis using anti-age antibodies or age antigens |
| EP4561696A1 (en) * | 2022-06-30 | 2025-06-04 | Mechanobiologics, Inc. | Reversal of cellular senescence by treatment with low frequency ultrasound |
| KR20260030241A (ko) * | 2024-08-27 | 2026-03-06 | 한국과학기술원 | 조직 내 최종당화산물 제거 방법, 및 이를 이용한 노화 억제 방법 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5624804A (en) | 1991-12-20 | 1997-04-29 | The Rockefeller University | Immunochemical detection of In vivo advanced glycosylation end products |
| US6380165B1 (en) | 1997-09-19 | 2002-04-30 | The Picower Institute For Medical Research | Immunological advanced glycation endproduct crosslink |
| US6067859A (en) | 1999-03-04 | 2000-05-30 | The Board Of Regents, The University Of Texas System | Optical stretcher |
| US7751057B2 (en) | 2008-01-18 | 2010-07-06 | The Board Of Trustees Of The University Of Illinois | Magnetomotive optical coherence tomography |
| RU2553225C2 (ru) * | 2008-05-23 | 2015-06-10 | Сива Корпорейшн | Способ облегчения регенерации |
| WO2011101039A1 (en) | 2010-02-22 | 2011-08-25 | Universite Pierre Et Marie Curie (Paris 6) | Apparatus for the treatment of brain affections and method implementing thereof |
| ES2725852T3 (es) * | 2010-09-27 | 2019-09-27 | Siwa Corp | Eliminación selectiva de células modificadas por AGE para el tratamiento de la aterosclerosis |
| US20140257262A1 (en) | 2013-03-11 | 2014-09-11 | Alexandre Carpentier | Interstitial ultrasonic disposable applicator and method for tissue thermal conformal volume ablation and monitoring the same |
| EP3194439B1 (en) | 2014-09-19 | 2022-01-19 | Siwa Corporation | Anti-age antibodies for treating inflammation and auto-immune disorders |
| US10358502B2 (en) | 2014-12-18 | 2019-07-23 | Siwa Corporation | Product and method for treating sarcopenia |
| US9993535B2 (en) | 2014-12-18 | 2018-06-12 | Siwa Corporation | Method and composition for treating sarcopenia |
| CN108431044A (zh) * | 2015-10-13 | 2018-08-21 | Siwa有限公司 | 抗age抗体及其使用方法 |
| US20210106849A1 (en) * | 2015-11-11 | 2021-04-15 | NaviFUS Co. Ltd. | Method and Kit for Treating Brain Tumor by using an Ultrasound System |
| HUE058854T2 (hu) | 2016-02-19 | 2022-09-28 | Siwa Corp | Módszer és készítmény a rák kezelésére, az áttétes rákos sejtek elpusztítására és a rák áttétképzõdésének megelõzésére a fejlett glikációs végtermékek (AGE) elleni antitest alkalmazásával |
| US10981021B2 (en) | 2016-03-11 | 2021-04-20 | Carthera | Method for transiently disrupting a region of the blood-brain barrier of a human |
| KR20180133452A (ko) | 2016-04-15 | 2018-12-14 | 시와 코퍼레이션 | 신경퇴행성 질환을 치료하기 위한 항-노화 항체 |
-
2019
- 2019-08-22 WO PCT/US2019/047762 patent/WO2020041625A1/en not_active Ceased
- 2019-08-22 EP EP19773968.3A patent/EP3840840A1/en active Pending
- 2019-08-22 US US17/268,413 patent/US20210253739A1/en not_active Abandoned
- 2019-08-22 JP JP2021507529A patent/JP2021534144A/ja active Pending
-
2024
- 2024-06-19 JP JP2024098654A patent/JP2024123124A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021534144A5 (https=) | ||
| JP2021532114A5 (https=) | ||
| JP2016519932A5 (https=) | ||
| Brand et al. | Secretory carrier membrane proteins 31-35 define a common protein composition among secretory carrier membranes. | |
| Deshpande | Enzyme immunoassays: from concept to product development | |
| BRPI0507433B8 (pt) | anticorpo monoclonal recombinante ou sua parte de ligação ao antígeno, composição, ácido nucleico isolado, vetor de expressão, e, kit | |
| WO2018057735A8 (en) | Antibodies for siglec-15 and methods of use thereof | |
| NZ701444A (en) | Antibodies to matrix metalloproteinase 9 | |
| NZ623541A (en) | Human cgrp receptor binding proteins | |
| JP2019522490A5 (https=) | ||
| JP2014502253A5 (https=) | ||
| Ding et al. | Complement-activating IgM enhances the humoral but not the T cell immune response in mice | |
| Reese et al. | Purification of animal immunoglobulin G (IgG) using peptoid affinity ligands | |
| Jones et al. | Isolation of immune complexes and characterisation of their constituent antigens and antibodies in some human diseases: a review | |
| EA201100741A1 (ru) | Антитела к модифицированным пептидам ифр-1/е человека | |
| US11169147B2 (en) | Method for immobilizing protein on particle | |
| WO2023196658A3 (en) | Antibody compositions and optimization methods | |
| Ma et al. | The purification of natural and recombinant peptide antibodies by affinity chromatographic strategies | |
| CN115362171A (zh) | 用于治疗冠状病毒的抗体、融合蛋白及其应用 | |
| Nakazawa et al. | Production and purification of polyclonal antibodies | |
| Yu et al. | Method for studying immunoglobulin G binding on hydrophobic surfaces | |
| Buza et al. | Trypanosome non-specific IgM antibodies detected in serum of Trypanosoma congolense-infected cattle are polyreactive | |
| Pechelyulko et al. | Comparative analysis of the efficiency of chicken and rabbit antibodies in competitive enzyme linked immunoassay for the detection of bovine beta-casomorphin 7 | |
| WO2015129651A1 (ja) | 改変単量体ＩｇＭ | |
| Ruffet et al. | Activation of the Classical Pathway of Complement by Non‐Immune Complexes of Immunoglobulins with Human Protein Fv (Fv Fragment‐Binding Protein) |